MFDA bans defective batch of injection for acidity treatment
MFDA stated that the batch in question, manufactured by India’s Aristo Pharmaceutical Pvt Ltd, has been found to have defects.
Maldives Food and Drug Authority (MFDA) on Thursday banned the import of a batch of Pentop 40 injection, used for treating gas and acidity, due to identified quality issues.
In a statement issued today, the MFDA stated that the batch in question, manufactured by India’s Aristo Pharmaceutical Pvt Ltd, has been found to have defects. The details of the batch are as follows:
-
Manufacturer: Aristo Pharmaceutical Pvt Ltd, India
-
Batch Number: EMPH243030
The MFDA has instructed importers to ensure compliance with the required standards for the transportation and storage of pharmaceuticals to maintain drug safety.
